Cancer diagnostics

VAR2 Pharmaceuticals aims to develop diagnostic tools based on our proprietary malaria protein which has unique affinity and specificity to distinct cancer-associated carbohydrates.

VAR2 Pharmaceuticals acknowledges the importance of developing companion diagnostics linking therapeutic potential with specific patient populations.

Our focus is to develop a universal method to capture circulating tumor cells and to detect onco-fetal CS in liquid biopsies